New, collaborative work from researchers’ team led by Dr. Shruti Bhatt at National University of Singapore and Dr. Letai at Dana-Farber Cancer Institute has succeeded in understanding the biology of relapsed cancer cells by using mouse models of acute myeloid leukemia (AML), highly aggressive blood cancer.